Abstract

Individuals with autism spectrum disorder (ASD) have social interaction deficits and difficulty filtering information. Inhibitory interneurons filter information at pyramidal neurons of the anterior cingulate cortex (ACC), an integration hub for higher-order thalamic inputs important for social interaction. Humans with deletions including LMO4, an endogenous inhibitor of PTP1B, display intellectual disabilities and occasionally autism. PV-Lmo4KO mice ablate Lmo4 in PV interneurons and display ASD-like repetitive behaviors and social interaction deficits. Surprisingly, increased PV neuron-mediated peri-somatic feedforward inhibition to the pyramidal neurons causes a compensatory reduction in (somatostatin neuron-mediated) dendritic inhibition. These homeostatic changes increase filtering of mediodorsal-thalamocortical inputs but reduce filtering of cortico-cortical inputs and narrow the range of stimuli ACC pyramidal neurons can distinguish. Simultaneous ablation of PTP1B in PV-Lmo4KO neurons prevents these deficits, indicating that PTP1B activation in PV interneurons contributes to ASD-like characteristics and homeostatic maladaptation of inhibitory circuits may contribute to deficient information filtering in ASD.

LMO4 has been linked genetically to autism spectrum disorder and intellectual disability. Here, the authors investigate a role of LMO4 in parvalbumin neurons and, specifically, the regulation of dorsal ACC inhibitory circuits.

Details

Title
Hyperactivated PTP1B phosphatase in parvalbumin neurons alters anterior cingulate inhibitory circuits and induces autism-like behaviors
Author
Zhang, Li 1 ; Qin Zhaohong 1 ; Ricke, Konrad M 2 ; Cruz, Shelly A 1 ; Stewart, Alexandre F, R 3 ; Chen Hsiao-Huei 4   VIAFID ORCID Logo 

 Ottawa Hospital Research Institute, Neuroscience, Ottawa, Canada (GRID:grid.412687.e) (ISNI:0000 0000 9606 5108); University of Ottawa Brain and Mind Institute, Ottawa, Canada (GRID:grid.28046.38) (ISNI:0000 0001 2182 2255) 
 Ottawa Hospital Research Institute, Neuroscience, Ottawa, Canada (GRID:grid.412687.e) (ISNI:0000 0000 9606 5108); University of Ottawa Brain and Mind Institute, Ottawa, Canada (GRID:grid.28046.38) (ISNI:0000 0001 2182 2255); University of Ottawa Heart Institute, Ottawa, Canada (GRID:grid.28046.38) (ISNI:0000 0001 2182 2255); University of Ottawa, Biochemistry, Microbiology and Immunology, Ottawa, Canada (GRID:grid.28046.38) (ISNI:0000 0001 2182 2255) 
 University of Ottawa Heart Institute, Ottawa, Canada (GRID:grid.28046.38) (ISNI:0000 0001 2182 2255); University of Ottawa, Biochemistry, Microbiology and Immunology, Ottawa, Canada (GRID:grid.28046.38) (ISNI:0000 0001 2182 2255); University of Ottawa, Centre for Infection, Immunity and Inflammation, Ottawa, Canada (GRID:grid.28046.38) (ISNI:0000 0001 2182 2255) 
 Ottawa Hospital Research Institute, Neuroscience, Ottawa, Canada (GRID:grid.412687.e) (ISNI:0000 0000 9606 5108); University of Ottawa Brain and Mind Institute, Ottawa, Canada (GRID:grid.28046.38) (ISNI:0000 0001 2182 2255); University of Ottawa, Centre for Infection, Immunity and Inflammation, Ottawa, Canada (GRID:grid.28046.38) (ISNI:0000 0001 2182 2255); University of Ottawa, Cellular and Molecular Medicine, Ottawa, Canada (GRID:grid.28046.38) (ISNI:0000 0001 2182 2255); Medicine, University of Ottawa, Ottawa, Canada (GRID:grid.28046.38) (ISNI:0000 0001 2182 2255) 
Publication year
2020
Publication date
2020
Publisher
Nature Publishing Group
e-ISSN
20411723
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2362206706
Copyright
This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.